Phage Therapy for the Prevention and Treatment of Pressure Ulcers.

Summary

This study will evaluate a topical bacteriophage therapy product (BACTELIDE) as an adjunct to standard therapy for the prevention and treatment of pressure ulcers colonized with S. aureus, P. aeruginosa, or K. pneumoniae species. This study will compare the safety and efficacy of BACTELIDE in conjunction with standard of care (SOC) versus a placebo in conjunction with standard of care.

Timeline

Start

2022-01

Primary completion

2023-08

Completion

2023-12

Drugs

Indications